New study explores simple tests to replace colonoscopies for colitis patients
NCT ID NCT07653750
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if certain substances in stool and blood can predict whether the gut lining has healed in people with moderate to severe ulcerative colitis. Researchers planned to measure these markers in 62 adults before and after treatment. The study was terminated early, so the full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple stool or blood test to check healing in ulcerative colitis, reducing the need for frequent colonoscopies.
- What could go wrong
- The study was terminated early, so results are limited. The markers may not be accurate enough to replace colonoscopy in all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
62 people
The number who actually took part.
- Started
-
Jun 2021
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with Ulcerative Colitis * Age ≥ 18 years * Presence of endoscopic activity (Mayo endoscopic score ≥ 2) requiring the introduction, increase or change of treatment * Patients able to consent Non Inclusion Criteria : * Patients not affiliated to the social security system * Pregnant or breastfeeding woman * Patients who have total coloproctectomy with ileo-anal anastomosis * Acute Severe Ulcerative Colitis (ASUC) * Persons under guardianship, trusteeship or imprisonment Exclusion Criteria: * Patient wishing to discontinue participation in the study for any reason * Study exit at the investigator's discretion * Pregnancy Discovery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Moderate to severe ulcerative colitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, Auvergne, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early symptom relief predict who stays on IBD biologic?
- Can a new pill tame ulcerative colitis?
- Could a new injection tame ulcerative colitis?
- New pill could tame severe gut disease
- New drug shows promise for ulcerative colitis sufferers
- Immune cell therapy takes on IBD: a new hope for tough cases?